MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.
Issue link: https://medesthetics.epubxp.com/i/111786
NEWS & EVENTS Roche-Posay (laroche-posay.us) donated 5,000 pieces of its advanced, broadspectrum UVA/UVB protection Anthelios Sunscreen Cream to the Mollie Biggane Melanoma Foundation. The Foundation increases awareness for melanoma prevention, provides information and services on skin cancer detection and supports melanoma patients with education on treatment options. ���We are honored to accept this donation on behalf of centers nationwide,��� said Jack Biggane, Mollie���s father and president of the Foundation. ���La Roche-Posay has impressed us so much with its dedication to educating people about skin health and its innovative, skin-nourishing formulations, and we���re excited to continue working with them for a second year.��� ���Education, protection and early detection make a difference,��� explains Angela Bennett, vice president of La Roche-Posay. ���Our research shows that 99% of skin cancer patients survive with early detection. By teaching people about the dangers of UV rays and providing products that help protect from the sun, we hope to help prevent new cases in the coming years.��� PHASE II RESULTS RELEASED FOR BIOLOGIC ACNE TREATMENT XBiotech, a privately held biotechnology company, has announced positive Phase II clinical trial results for True Human monoclonal antibody MABp1in the treatment of acne vulgaris. The trial was conducted as an open label study using True Human���the ���rst biologic therapy targeting the in���ammatory cytokine IL-1�����in patients with moderate to severe acne. The company reports that patients enrolled in the study demonstrated continual improvement in lesions over the course of therapy, with up to 42% reduction in eight weeks. The strong initial results in this trial provide the basis for further development of the product. Whatever you need, we���ve got you covered With our 3 creamy mineral foundations each with soothing zinc oxide, SPF 20, superior coverage and a natural looking fnish 1-916-939-9888 1-800-476-0226 toll free w w w. i l l u m i n a re c o s m e t i c s . c o m 78 MARCH/APRIL 2013 | MedEsthetics The Phase II clinical trial was a multicenter study that included investigators such as Ronald Moy, MD, past-president of the American Academy of Dermatology and chief of dermatological surgery at UCLA Medical Center. ���We believe that our True Human monoclonal antibody therapy has the potential to provide a completely new biologic approach to the management of acne,��� said John Simard, president and CEO of XBiotech. ���The safety of our technology, which has been well established with 145 patients receiving over 450 doses of MABpl, allows us to focus on a variety of indications, including those that are non-life threatening such as acne. As with other conditions involving chronic in���ammation, IL-1�� plays a signi���cant role in the acne disease process, and neutralizing its effects with MABp1 shows highly promising early results. The opportunity to address a common, yet challenging, skin condition with a novel, biological drug represents a signi���cant development in dermatological care.��� GREATINJECTORS.COM WEBSITE LAUNCHES Physicians who offer cosmetic injectables now have a new tool available to reach prospective patients. Medical Media Management, a New York state corporation specializing in lead generation for cosmetic physicians, has announced the launch of GreatInjectors.com. The site provides patient information on all injectable products and treatments. Visitors to the site can also ���nd physicians who offer these procedures in their region. ���The competition for cosmetic patients has become extreme and the cost of acquisition of these patients continues to rise. We believe we have created a formula to allow practitioners to differentiate themselves from their local competitors in a professional manner without increasing their advertising budget,��� said Wayne